Overview of innovation

Researchers at Stellenbosch University have developed a proprietary buffer that enables a high-temperature (50°C) IVT process, solving a key industry challenge. Unlike standard buffers that suffer a ~40% yield loss at high temperature, this formulation maintains ~93% RNA yield with standard enzyme loads while concurrently reducing immunogenic dsRNA impurities. This dual benefit of significantly higher yield and superior purity de-risks manufacturing, lowers production costs, and enhances the safety profile of the final mRNA product.

Type of Intellectual Property protection
Know how
Innovation Opportunity Type
Licensing
Partnership
Industry
​Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Professional, scientific and technical activities
Scientific research and development
Human health and social work activities
Human health activities
Technology Readiness Level
TRL 5 – Prototype tested in a controlled environment
Website link
https://app.in-part.com/university-dashboard/technologies/24320